The effects of hormone therapy on cognition in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 86, Issue 3-5, 2003, Pages 405-412

  Shilling, Valerie ^a   Jenkins, Valerie ^a   Fallowfield, Lesley ^a   Howell, Tony ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Hormonal therapy; Memory; Oestrogen

Indexed keywords

ANASTROZOLE; ANTIESTROGEN; HORMONE; TAMOXIFEN;

ADULT; AGED; ATTENTION; BRAIN FUNCTION; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN DEFICIENCY; FEMALE; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MEASUREMENT; MEMORY; MORBIDITY; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; TIME; VELOCITY; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

EID: 0242541269     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2003.07.001     Document Type: Conference Paper

References (41)

1. Shilling V., Jenkins V., Fallowfiled L., Howell A. The effects of oestrogens and anti-oestrogens on cognition. Breast. 10:2001;484-491.
2. Drake E.B., Henderson V.W., Stanczyk F.Z., McCleary C.A., Brown W.S., Smith C.A., Rizzo A.A., Murdock G.A., Buckwalter J.G. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology. 54:2000;599-603.
3. Wolf O.T., Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm. Behav. 41:2002;259-266.
4. Barrett-Connor E., Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J. Am. Geriatr. Soc. 47:1999;1289-1293.
5. Yaffe K., Grady D., Pressman A., Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J. Am. Geriatr. Soc. 46:1998;816-821.
6. Yaffe K., Lui L.Y., Grady D., Cauley J., Kramer J., Cummings S.R. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet. 356:2000;708-712.
7. Rice M.M., Graves A.B., McCurry S.M., Gibbons L.E., Bowen J.D., McCormick W.C., Larson E.B. Post-menopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. Arch. Intern. Med. 160:2000;1641-1649.
8. Steffens D.C., Norton M.C., Plassman B.L., Tschanz J.T., Wyse B.W., Welsh-Bohmer K.A., Anthony J.C., Breitner J.C. Enhanced cognitive performance with estrogen use in non-demented community-dwelling older women. J. Am. Geriatr. Soc. 47:1999;1171-1175.
9. Kampen D.L., Sherwin B.B. Estrogen use and verbal memory in healthy post-menopausal women. Obstet. Gynecol. 83:1994;979-983.
10. Maki P., Zonderman A., Resnick S. Enhanced verbal memory in non-demented elderly women receiving hormone-replacement therapy. Am. J. Psychiatr. 158:2001;227-233.
11. Fluck E., File S.E., Rymer J. Cognitive effects of 10 years of hormone-replacement therapy with tibolone. J. Clin. Psychopharmacol. 22:2002;62-67.
12. Shaywitz S.E., Shaywitz B.A., Pugh K.R., Fulbright R.K., Skudlarski P., Mencl W.E., Constable R.T., Naftolin F., Palter S.F., Marchione K.E., Katz L., Shankweiler D.P., Fletcher J.M., Lacadie C., Keltz M., Gore J.C. Effect of estrogen on brain activation patterns in post-menopausal women during working memory tasks. JAMA. 281:1999;1197-1202.
13. Resnick S.M., Maki P.M., Golski S., Kraut M.A., Zonderman A.B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 34:1998;171-182.
14. Maki P.M., Resnick S.M. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage. 14:2001;789-801.
15. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in post-menopausal women: effects on cognitive function and dementia. JAMA. 279:1998;688-695.
16. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 283:2000;1007-1015.
17. Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., Yu H.Y., Wang S.J., Liu H.C. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology. 54:2000;2061-2066.
18. Henderson V.W., Paganini-Hill A., BL M. Estrogen for Alzheimer's disease in women. Neurology. 54:2000;295-301.
19. Asthana S., Baker L.D., Craft S., Stanczyk F.Z., Veith R.C., Raskind M.A., Plymate S.R. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 57:2001;605-612.
20. Asthana S., Craft S., Baker L.D., Raskind M.A., Birnbaum R.S., Lofgreen C.P., Veith R.C., Plymate S.R. Cognitive and neuroendocrine response to transdermal estrogen in post-menopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology. 24:1999;657-677.
21. Birge S.J., Mortel K.F. Estrogen and the treatment of Alzheimer's disease. Am. J. Med. 103:1997;36S-45S.
22. Honjo H., Ogino Y., Naitoh K.et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo controlled double-blind study. J. Japanese Menopause Soc. 1:1993;167-171.
23. Nickelsen T., Lufkin E.G., Riggs B.L., Cox D.A., Crook T.H. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in post-menopausal women. Psychoneuroendocrinology. 24:1999;115-128.
24. Yaffe K., Krueger K., Sarkar S., Grady D., Barrett-Connor E., Cox D.A., Nickelsen T. Cognitive function in post-menopausal women treated with raloxifene. N. Engl. J. Med. 344:2001;1207-1213.
25. L. Baker, Raloxifene: cognitive-enhancing effects for post-menopausal women with AD, in: Proceedings of the Paper Presented at the World Alzheimer Conference, Washington, DC, 2000.
26. Paganini-Hill A., Clark L.J. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res. Treat. 64:2000;165-176.
27. Ernst T., Chang L., Cooray D., Salvador C., Jovicich J., Walot I., Boone K., Chlebowski R. The effects of tamoxifen and estrogen on brain metabolism in elderly women. J. Natl. Cancer Inst. 94:2002;592-597.
28. H Nelson, National Adult Reading Test (NART) Manual, second ed., NFER Nelson, 1991.
29. D Wechsler, Wechsler Memory Scale, third ed., Harcourt Brace and Co., London, 1998.
30. D Kendrick, G. Watts, The Kendrick Assessment Scales of Cognitive Ageing, NFER Nelson, 1999.
31. Broadbent D., Cooper P., Fitzgerald P., Parkes K. The cognitive failures questionnaire and its correlates. Br. J. Clin. Psychol. 21:1982;1-16.
32. Beck A., Ward C., Mendelsohn M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatr. 4:1961;561-571.
33. Phillips S.M., Sherwin B.B. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology. 17:1992;497-506.
34. File S.E., Jarrett N., Fluck E., Duffy R., Casey K., Wiseman H. Eating soya improves human memory. Psychopharmacology (Berl.). 157:2001;430-436.
35. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 101:2000;485-512.
36. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
37. van Dam F., Schagen S., Muller M., Boogerd W. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high dose versus standard dose chemotherapy. J. Natl. Cancer Inst. 90:1998;210-218.
38. Ross J.L., Roeltgen D., Feuillan P., Kushner H., Cutler G.B. Jr. Effects of estrogen on non-verbal processing speed and motor function in girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 83:1998;3198-3204.
39. Coster S., Poole K., Fallowfield L.J. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res. Treat. 68:2001;273-282.
40. Neele S., Rombouts A., Bierlaagh M., Barkhof F., Scheltens P., Netelenbos J. Raloxifene affects brain activation patterns in post-menopausal women during visual encoding. J. Clin. Endocrinol. Metab. 86:2001;1422-1424.
41. Peto R. Mortality from breast cancer in UK has decreased suddenly. BMJ. 317:1998;476-477.